| |
|
|
||
              
|
Dr. Andrew Storer - Biography
 Dr. Andrew Storer
Dr. Andrew Storer has been the Director of the Pharmaceutical Biotechnology Sector (recently renamed the Health Sector) of the BRI since 1990. He joined the NRC as a Research Associate at the Institute of Biological Sciences in Ottawa in 1977 and transferred to the NRC Biotechnology Institute (BRI) in Montréal in 1987 to establish an enzymology group. He obtained his Ph.D. in Biochemistry at the University of Birmingham, U.K., in 1975. This was followed by a post-doctoral fellowship with Dr. G. G. Hammes in the Chemistry Department, Cornell University. He is currently an adjunct professor in the Biochemistry Department of McGill University and a member of the Protein Engineering Network of Centres of Excellence. His research interests include the development of enzyme structure-function databases for use in the design of novel inhibitors with therapeutic potential. He has over one hundred referenced publications. In 1998, Dr. Storer joined the MRC Genome Task Force and, until March 2000, served as a member of the Genome Canada Science and Strategy Committee. In September 1999, Dr. Storer took on additional responsibilities as the Coordinator of the New Multi-Institute NRC Initiative in Genome Sciences and Health-Related Research. To know more about the Health Sector research activities, please visit the Health Sector section on the NRC-BRI web site.
|
 
|
